相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Evolution of STING Signaling and Its Involvement in Cancer
Nimi Vashi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2021)
GBP5 drives malignancy of glioblastoma via the Src/ERK1/2/MMP3 pathway
Xiaoting Yu et al.
CELL DEATH & DISEASE (2021)
Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling
Jing Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer
John Kwon et al.
CANCER DISCOVERY (2020)
Oncogenic Role of Guanylate Binding Protein 1 in Human Prostate Cancer
Jing Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
GBP1 promotes erlotinib resistance via PGK1-activated EMT signaling in non-small cell lung cancer
Lifang Cheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma
Junhui Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway
Shuye Yu et al.
ONCOGENE (2020)
Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy
Juyan Zheng et al.
MOLECULAR CANCER (2020)
DNA Damage and Cancer Immunotherapy: A STING in the Tale
Timo Reislander et al.
MOLECULAR CELL (2020)
The Impact of Radiation-Induced DNA Damage on cGAS-STING-Mediated Immune Responses to Cancer
Quinn Storozynsky et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The interactions between cGAS-STING pathway and pathogens
Zhangliang Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
DUB3 deubiquitinates and stabilizes NRF2 in chemotherapy resistance of colorectal cancer
Qi Zhang et al.
CELL DEATH AND DIFFERENTIATION (2019)
Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease
Kyle Tretina et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma
Petri Polonen et al.
ONCOGENE (2019)
Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression
Jianfa Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
p62 acts as an oncogene and is targeted by miR-124-3p in glioma
Danni Deng et al.
CANCER CELL INTERNATIONAL (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis
Hui Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
NRF2 and the Hallmarks of Cancer
Montserrat Rojo de la Vega et al.
CANCER CELL (2018)
Attenuation of cGAS-STING signaling is mediated by a p62/SQSTM1-dependent autophagy pathway activated by TBK1
Thaneas Prabakaran et al.
EMBO JOURNAL (2018)
The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer
Tuo Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach-Klonisch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
In-geun Ryoo et al.
REDOX BIOLOGY (2018)
Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
Gillian Dunphy et al.
MOLECULAR CELL (2018)
CDK4/6 inhibition is more active against the glioblastoma proneural subtype
Ming Li et al.
ONCOTARGET (2017)
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
Melissa Quintero et al.
BMC CANCER (2017)
Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
Anju Singh et al.
ACS CHEMICAL BIOLOGY (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
p62 in Cancer: Signaling Adaptor Beyond Autophagy
Jorge Moscat et al.
CELL (2016)
Interferon-Inducible GTPases in Host Resistance, Inflammation and Disease
Danielle Pilla-Moffett et al.
JOURNAL OF MOLECULAR BIOLOGY (2016)
NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells
Clarissa Ribeiro Reily Rocha et al.
ONCOTARGET (2016)
Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
Tianli Xia et al.
CELL REPORTS (2016)
p38 MAPK-dependent Nrf2 induction enhances the resistance of glioma cells against TMZ
Leina Ma et al.
MEDICAL ONCOLOGY (2015)
Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance
Motoi Fukumoto et al.
CANCER SCIENCE (2014)
Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells
Zi-Xiang Cong et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response
Patricio Godoy et al.
BREAST CANCER (2014)
A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication
Alexandra Nordmann et al.
FASEB JOURNAL (2012)
Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
Ming Li et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interferon-inducible guanylate binding protein (GBP)-2: A novel p53-regulated tumor marker in esophageal squamous cell carcinomas
Denise P. Guimaraes et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
Gaspar J. Kitange et al.
NEURO-ONCOLOGY (2009)
A genomic screen for activators of the antioxidant response element
Yanxia Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
GBP1 overexpression is associated with a paclitaxel resistance phenotype
ZF Duan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
分享论文
